SWOT analysis.

<p>Summarized results of the SWOT analysis, outlining the most important, critical and relevant points for each internal and external factors.</p

Adhesion to the system, number of first and second subnational administrative level units for cutaneous and mucosal leishmaniasis, and annual deadline from 2012 to 2015 in the Americas.

<p>Adhesion to the system, number of first and second subnational administrative level units for cutaneous and mucosal leishmaniasis, and annual deadline from 2012 to 2015 in the Americas.</p

Number and percentage of cases with information unknown from the total cutaneous/mucosal and visceral leishmaniasis cases of different variables in SisLeish, from 2012 to 2015.

<p>Number and percentage of cases with information unknown from the total cutaneous/mucosal and visceral leishmaniasis cases of different variables in SisLeish, from 2012 to 2015.</p

Description of the variables available in SisLeish.

<p>Description of the variables available in SisLeish.</p

Delay in the insertion of data into SisLeish.

<p>Boxplots presenting the delay (days after the established date) in the insertion of the information into SisLeish by the countries per year. In this graph, the rectangle (box) reflects the values between quartile 1 and 3, which is where 50% of the central data of the distribution of results (time delay) is located. The widest line in the box is the median, which is the observation point that leaves 50% of the data below and 50% above. The "arms" above and below the box represent the maximum and minimum values. Outliers or extreme values (those values that are widely scattered compared to core data) are presented as points outside the arms.</p

Description of the indicators available in SisLeish.

<p>Description of the indicators available in SisLeish.</p

SisLeish data flow.

<p>Diagram representing the information data flow of SisLeish.</p

Map of adhesion to SisLeish.

<p>Maps displaying the adhesion of the countries at the second subnational administrative level for cutaneous/mucosal leishmaniasis from 2012 (map on the left) and 2015 (map on the right) in the Americas. Source. SisLeish-PAHO/WHO: Data reported from the Regional Programs for Leishmaniasis/Surveillance Services. Data available in February, 2017.</p

Convergence : mensuel de la solidarité / Secours populaire français ; dir. publ. Julien Lauprêtre ; réd. Antonio Garcia, Valmont Ponceau

avril 20052005/04 (N247)-2005/04.Appartient à l’ensemble documentaire : UnivJeun

Dog vaccine expenditure for years 2013–2014 showing the average unit cost per dose and type of vaccine (Nerve Tissue Vaccines (NTV) vs. cell culture) as reported by the countries, the number of doses applied, and the estimated total expenditure on vaccine (only vaccine, not including logistics costs) for 16 LAC countries.

<p>Dog vaccine expenditure for years 2013–2014 showing the average unit cost per dose and type of vaccine (Nerve Tissue Vaccines (NTV) vs. cell culture) as reported by the countries, the number of doses applied, and the estimated total expenditure on vaccine (only vaccine, not including logistics costs) for 16 LAC countries.</p